Phalanx Licenses Rosetta Resolver System | GenomeWeb

NEW YORK (GenomeWeb News) – Phalanx Biotech Group has licensed Rosetta Biosoftware's Resolver system for use in its high-throughput gene expression and miRNA profiling services.

Rosetta said that its software system will enable the Taiwan-based microarray and genomics services firm to meet data management and analysis requirements associated with high sample volumes and will facilitate collaboration and results sharing between Phalanx and its customers.

Financial terms of the license were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.